Foshan RuiTong Consulting Co., Ltd. (afterwards abbreviated as RuiTong) supports Henan Topfond Sci-Tech Co.,Ltd. (afterwards abbreviated as Topfond Sci-Tech) to prepare for US FDA on-site inspection since March 06, 2023. Under the comprehensive guidance from RuiTong, RuiTong supports Topfond Sci-Tech to identify risks and prevent risks and improves relevant deficiencies to ensure quality system of Topfond Sci-Tech complies with requirements of GMP and cGMP. The Simvastatin API and quality system of Topfond Sci-Tech was inspected by US FDA inspector on July 31, 2023 to August 04, 2023 and finally passed US FDA on-site inspection with zero deficiency.

FDA issued the EIR for Topfond Sci-Tech on March 16，2024. Up to now, US FDA inspection project of Topfond Sci-Tech has been successfully concluded!

RuiTong throughout insists vision with “Customer Focus, Result oriented” and help customer do every detail well really on GMP and drug registration. If you need to know more about our services related to GMP and drug registration (CEP/DMF/ASMF/PQ), please do not hesitate to contact us.

Foshan RuiTong Consulting Co., Ltd.

Room 803, Fuwei Building, Huangqi GuangFo Road 1, Dali Town, Nanhai District, Foshan City, Guangdong Province, 528248, China

Website: http://www.gdruitong.cn/

Tel: +86-13660057841, +8613695153512